This action might not be possible to undo. Are you sure you want to continue?
To subscribe, visit alternative-therapies.com.
STACIE GELLER, PhD: FURTHERING THE ROLE OF WOMEN IN HEALTH CARE Interview by Frank Lampe and Suzanne Snyder • Photography by Doreen Birdsell
Stacie Geller, PhD, is the G. William Arends Professor of Obstetrics and Gynecology at the University of Illinois College of Medicine. She is the Director of the UIC Center for Research on Women and Gender and the National Center of Excellence in Women’s Health. In her role as director of two UIC centers, she promotes collaborative multidisciplinary work related to women’s lives. Dr Geller is a health services researcher and epidemiologist with expertise in women’s health issues, complementary and alternative medicine, and maternal mortality and morbidity and has published extensively in these areas. She has had a well-established national and international research career and has been awarded numerous research grants from the National Institutes of Health and other federal agencies and foundations. Dr Geller has also been actively involved in leadership and mentoring activities for women and under-represented minorities on the UIC campus. Dr Geller has been studying maternal mortality and morbidity since 1999. She was the principal investigator of a Centers for Disease Control and Prevention/Association of Schools of Public Health cooperative agreement, “Investigation of factors associated with maternal mortality.” She developed an innovative model for early identiﬁcation of high-risk women that has garnered national attention. Dr Geller’s work in maternal mortality and morbidity extends to international circles. She recently completed a 5-year National Institute of Child Health and Human Development randomized clinical trail comparing the use of oral misoprostol compared to standard of care to reduce postpartum hemorrhage in rural India. She is currently working with the MacArthur Foundation and Pathfinder International to implement a continuum of care model to reduce postpartum hemorrhage in India, Nigeria, and Ghana. Dr Geller has been working with the state of Illinois for the past 10 years to enhance surveillance for maternal mortality and morbidity. She was a founding member of and currently sits on the Illinois Maternal Mortality Review Committee and is responsible for review of preventability issues for all maternal deaths in the state. Over the past several years, Dr Geller has mentored a number of doctoral candidates, primarily in the UIC School of Public Health and the College of Nursing as well as a number of clinical postdoctoral fellows in the College of Medicine. She also has worked closely with junior faculty for training and career planning. Prior to being funded for the Building Interdisciplinary Research Careers in Women’s Health program, she cofounded the Interdisciplinary Women’s Health Research program to provide senior faculty support to junior faculty who are interested in women’s health research. Junior faculty scholars are advised by an interdisciplinary group of senior women’s health research faculty and are paired with two senior faculty mentors. Mentoring activities address research proposal development, research methodology, preparation of materials for publication and presentation, funding, and other research issues.
Alternative Therapies in Health and Medicine (ATHM): What is your background and history, and how did you come to specialize in women’s issues? Dr Geller: I’ve been involved in women’s health care in one way or another for most of my career. In my early days, I was the executive director of a women’s health center that was begun as part of the feminist women’s health movement in the 1970s that worked to empower women as health care consumers. It was a women’s health center that was jointly run by health care providers: doctors, nurses, social workers, and therapists, as well as lay health workers and health educators. We cared for all women who came to the clinic regardless of their ability to pay. It was a cooperative structure, so there was not the usual hierarchy of doctors at the top and educators or patients at the bottom. We all worked together collaboratively and practiced integrative medicine before the phrase integrative medicine became trendy. We just did it naturally. We saw a place for traditional medicine in the Western sense, conventional, allopathic medicines, but we also saw the importance of other, more nontraditional or alternative therapies or medications and that the two could be integrated well together. I did that for a number of years. In 1987, my husband, son, and I moved from Chicago to Tucson, Arizona. I went back to school for a master’s degree in public policy, primarily focused on health policy. I was doing rural health work and some work with women living in border communities. I started to teach and to do some small research projects, and I realized that I enjoyed doing research and decided to go back to school to get a PhD. My PhD was in medical decision making because it was an area that interested me: how health consumers, primarily women, but health consumers in general, make decisions about their health care or don’t make Opposite: Dr Geller, shown here at her ofﬁce at the Center for Research on Women and Gender, University of Illinois College of Medicine, believes that women tend to be forgotten in health care.
ALTERNATIVE THERAPIES, jan/feb 2010, VOL. 16, NO. 1
Conversations: Stacie Geller, PhD
Conversations: Stacie Geller. jan/feb 2010. 16. 1 67 . NO. PhD ALTERNATIVE THERAPIES. VOL.
The reason I like the work I am doing now is that a lot of my work is very practical and hands-on and translational. 1 Conversations: Stacie Geller. PhD TK . Then my husband and I came back to Chicago. I went to University of Michigan at Ann Arbor and did a postdoctoral fellowship in epidemiology—probably what now would be called “clinical translational research. “You should be a mid-wife. they weren’t as popular with women. and my working hypothesis was that women. it was in a clinical department in a college of medicine. This is a natural intersection of my two interests. But when I went back to school. and it’s an interest of mine. When I ﬁnished that. I was trained as a lay mid-wife and helped with deliveries and took care of pregnant women. of breast cancer. ATHM: Does your background in epidemiology serve you well in the work you’re doing in women’s health? Dr Geller: Very much so because it helps me understand risk factors that may predispose a woman to poor health.decisions. if offered an alternative of any kind—be it less invasive surgery or homeopathic medication. The theory was that women didn’t have to be 100% better. I saw myself as much more hands-on. you went through menopause. it was clinically focused and very translational. I have the medical background in women’s health. when I got a faculty position.” Even though it was an epidemiologic fellowship. and I wasn’t sure that I could deal well with the very structured. and that’s what I found in the PhD program. you were put on hormones for the rest of your life to prevent all of these chronic conditions of aging that hormones hadn’t been shown to be efﬁcacious for. The Women’s Health 68 ALTERNATIVE THERAPIES. a lot of women who had dysfunctional or abnormal uterine bleeding were getting hysterectomies. Look at menopause and the use of hormone therapy for menopausal women.” which is what usually happened to women. for example—would be interested in trying that. for example. Now there is this new phrase. NO. by default. This has been the right choice for me. and everyone said. This is especially true for my global health work. VOL. But I really wanted to learn the other piece of it. I thought about applying to medical school as well as for the PhD. We take a population-based perspective. and I was interested in understanding why women might choose an alternative to that. You look at the risk. that there is always an individual patient focus. For many years. I wanted to be able to do it in a meaningful way. Although hysterectomies were very popular with physicians at the time. I see a lot of doctors get their clinical degrees and then go back and get a master’s in something. they just had to be better enough to improve their quality of life. regimented memorization it would take to go to medical school. whether it be alternative therapies or a less invasive surgery. One of the problems in doing research in medicine is that clinicians are singly focused on the individual patient and understandably so. jan/feb 2010. I was older. where I focus on improving the pregnancy and delivery outcomes for women living in rural villages in Africa and India. real world.” The inter- esting thing was no one said. 16. When I worked at the clinic. I have been involved in research projects in women’s health for the past 12 years. I wanted to go back to school to be creative. “You have to be a doctor. At the time. What I like about epidemiology and public health is it allows us to take a broader perspective. and it helps me think more broadly. Speciﬁcally. I’ve always stayed in medicine. I found it stimulating and creative. and I wanted to learn it well. for instance. Had somebody said back in those early days when I was running a women’s health center that I would be a professor of obstetrics and gynecology now. ATHM: Why did you choose to pursue an academic career over a medical one? Dr Geller: It was actually a very hard decision for me. how to do the science and move the medical ﬁeld forward. in fact. and they don’t really have the capacity to do research well. patient-centered care. which is funny to me because probably most physicians would say they have been practicing patient-centered care all along. you’re so good at this. That’s what I think about when I think about clinical care. I enjoyed getting the PhD. so I stay up on it. I probably would have laughed at them because I never saw myself as an academic. I worked on decision making for women with abnormal uterine bleeding. I focused on that work for a couple of years. and I got a job at the University of Illinois and began doing research in women’s health.
They get infections. We all get old. “I told you so. because I don’t think there is a magic pill. The ability of pregnant women to metabolize drugs is greater with some drugs and less with others depending on how the liver metabolizes the drug. so they have to take antibiotics. It is not as if pregnant women don’t take drugs. VOL. There are alternatives to hormone therapy for those women who either can’t take hormone therapy because they are at risk or choose not to because they don’t believe in taking exogenous hormones. I felt that the data were unclear. it is trying to live the healthiest lifestyle we possibly can with exercise. I did not believe. If you fund research. red clover. they take drugs all the time. there were probably twenty thousand excess breast cancer cases in a given year because of this overuse of hormone therapy. So I started looking into alternative therapies and what women were taking. 1 69 . women had to be in the clinical trials because clinical trials were being traditionally done on men. As a scientist. NO. plus a host of other symptoms. But the group that bothered me was the menopausal symptomatic women. And I wasn’t convinced it was protective for the brain or for Alzheimer’s. W Dr Geller: Let me give you a little background. jan/feb 2010. But if you look across the population of women. Most of the studies had been done outside of the United States. and one of the things that I found is that there was this incredible use of botanicals and dietary supplements of all kinds: black cohosh. So we have done a few studies funded by the US Food and Drug Administration (FDA): one on antibiotics and one on an antihypertensive medication. and lots of others. but we don’t know if they metabolize them at the same rate as nonpregnant women. I don’t think there is a magic bullet. and I did believe it had a lot of risk factors. looking at how pregnant and nursing women metabolize drugs compared to nonpregnant and nonlactating women. ATHM: You were involved in studies to examine the pharmacokinetics of pharmaceuticals in pregnancy and the potential relevance of these effects in explaining differences in drug response between men and women. most scientists are exceedingly reluctant to study pregnant women. 16. That was before the Women’s Health Initiative results came out.Initiative data showed that for any individual woman. diet. Can you tell us about that? Dr Geller: The National Institutes of Health (NIH) mandated in 1993 that women had to be included in clinical trials. as did the vast majority of gynecologists. The reason I got interested in studying botanicals and dietary supplements for menopause is two-fold. so I thought I should study these botanicals and dietary supplements Conversations: Stacie Geller. If there is a magic bullet. There are a lot of medications that pregnant women have to take. which doesn’t make them bad. What I like about public health and epidemiology is it takes you out of the medical perspective of looking at the individual and allows you to look at the broader public health effects of various treatments. I was one of those people who was really outspoken in the days of the overabundance of hormone use for not only women who are going through menopause and are symptomatic but for long-term protective effects for things like cardiovascular disease. PhD ALTERNATIVE THERAPIES. Is there an area that you are focusing on within menopause? HAT I LIKE ABOUT PUBLIC HEALTH AND EPIDEMIOLOGY IS IT TAKES YOU OUT OF THE MEDICAL PERSPECTIVE OF LOOKING AT THE INDIVIDUAL AND ALLOWS YOU TO LOOK AT THE BROADER PUBLIC HEALTH EFFECTS OF VARIOUS TREATMENTS. probably less than one-tenth of 1%. Because pregnant women metabolize drugs differently than nonpregnant women do. The inclusion of women has increased greatly over the years. ATHM: Menopause is a broad umbrella that encompasses many other issues and symptoms for women. the risk of breast cancer is very small. that hormone therapy was protective for heart disease. soy. and we know almost nothing about drug metabolism in pregnant women. chronic health conditions. weight control—all those things we know about but nobody ever likes to talk about. I felt the evidence for their effectiveness was limited and the evidence for their safety was even more limited. However. which are profoundly affecting quality of life both in terms of their functioning during the day as well as their sleep at night. One. not so much for long-term. and they need to use inhalers. I was pretty popular when those results came out. but there may not have been the sort of rigor clinically that one would see with an NIHfunded study. dosing of medication in pregnancy is drug-speciﬁc. I was on a lot of talk shows saying in the most professional way possible.” But I became interested before that in studying alternative therapies for women. They are having primarily vasomotor symptoms. they have asthma.
there could have been issues of dosage. stress. We do not see data to date that show any improvement with the use of hormone therapy. We did a phase I study to test for short-term safety for the highest safe dose that we felt we could use. o Dr Geller: My position on hormone replacement therapy is it is one short-term option for women with moderately severe to severe symptoms of menopause. and a hormone arm. It is worth studying because 70 ALTERNATIVE THERAPIES. We had four arms in the study: a black cohosh arm.” For someone who does not have contraindications. “Try it for 6 months to a year. heart disease. They developed our own black cohosh and red clover products. I don’t know what that means. “Okay. One of the things we know is that hormones work for reduction of vasomotor symptoms. Women can just walk in and buy anything they want and take it in any dose they want. Things are not standardized. but they’re really regulated by the Dietary Supplement Health and Education Act. a red clover arm. try to taper yourself off. won’t talk about the constituents of their products. They come under the FDA. which funded the study. too. Then we moved in to the phase II study. Almost anything can be bought over the counter. Most of those women had comorbidities and maybe shouldn’t have been using black cohosh. a window of opportunity: if you don’t start women young enough. In the case of liver toxicity and black cohosh. or of any botanicals. Botanicals are not regulated in the way that Western medicine is regulated. and all the women in our study had to have an intact uterus because one of the things that NIH. and we don’t necessarily know about purity. and they won’t talk about what they believe the mechanism of action is. other chronic conditions that could be associated with menopause but could also associated with aging—the data are out. on the endometrium. a placebo arm. especially for heart disease. ATHM: What is your position on hormone replacement therapy? UR STUDY ISN’T THE FIRST STUDY TO SHOW THIS: YOU GIVE MENOPAUSAL WOMEN WHO ARE HAVING PRIMARILY VASOMOTOR SYMPTOMS A PILL—EVEN IF IT’S A “SUGAR” PILL— AND THEY GET BETTER. so that slowed us down. in fact. We are just starting it. In my opinion. was interested in was the safety of black cohosh and red clover. primarily for vasomotor symptoms. but none of this had been carefully studied. 16. Our study isn’t the ﬁrst study to show this: you give menopausal women who are having primarily vasomotor symptoms a pill—even if it’s a “sugar” pill— and they get better. especially in Germany. People are studying it now. What you see is not necessarily what you get. It is an interesting hypothesis. I’m going to study this. hormone therapy could be a shortterm solution.” I worked with our College of Pharmacy. so we are doing another NIH-funded study looking at the effect of soy on both cognition and anxiety. We’ve been very open about all of that. who truly has a poor quality of life due to vasomotor symptoms. What we found is that neither black cohosh nor red clover was signiﬁcantly better than placebo for relief. and we are comparing it to placebo and to hormone therapy. jan/feb 2010. which took a long time because we were looking for a fairly healthy population. A lot of companies.and see whether they work. see how you feel. but it is a pretty interesting phenomenon. vaginal atrophy. I know there is this big discussion right now about a critical window. and anxiety. the gold standard. What is short-term? I say to women. There were also a lot of women who didn’t want to be randomized to the hormone arm because by that time the Women’s Health Initiative had come out. A third of all menopausal women don’t have a uterus because they’ve had hysterectomies. and I’m going to do it in a rigorous scientiﬁc manner. we knew it was pure. 1 Conversations: Stacie Geller. A third of the women in the black cohosh group got better. what you see is what you get. One of the other issues is that most botanicals and dietary supplements have very limited regulation. We wanted a hormone arm because we wanted an arm in the study that we knew was a positive control that was. So I decided. who is not opposed to hormone therapy. VOL. and 60% of the women in the red clover and placebo groups got better. which is sort of an interesting story in itself. it is very limited and inadequate regulation. The bottom line is all of the women got better. With regard to other symptoms—cognitive decline. NO. A lot of women report anxiety. sleep related to vasomotor symptoms. We knew exactly how it was standardized. If you take amoxicillin. ATHM: Are you continuing to study those herbs or any other substances to mitigate the symptoms of menopause? Dr Geller: I’m doing another study now with a colleague of mine because the other areas that interest me are cognition. contamination and impurity of product. There have been hormone studies that have shown that. then they won’t get the advantage. PhD .
My concern is that they use a product that we know something about. ATHM: We continue to hear criticism from mainstream medicine about a lack of credible science behind a number of dietary supplements. they are more in question because there haven’t been good safety and efﬁcacy studies conducted. Women don’t talk to their health care providers. Share that with us. The Germans.” The potential harm that they can do is huge and largely undocumented to date. jan/feb 2010. ATHM: The challenge. That is a big problem. Isn’t that an interesting question? But we don’t study it. I think women are going to continue to use it. There is also the question of whether there are any botanical dietary supplements that have been proven to work for vasomotor symptoms. “Great. Selective serotonin reuptake inhibitors (SSRIs). the HALT study from Seattle. and another done at Columbia. let other people test it. In fact. who use other products. 16. 1 71 . well carried out studies with standardized products. as they are called. which means independent. People say they are natural. They did not ﬁnd an effect either. And it’s certainly not like the pharmaceutical companies who are developing more traditional Western drugs are not making money. And to that I say. people won’t stop talking about it. I was sure that black cohosh was going to work. There are other possibilities. so I worry about the idea of women saying. and that they inform their health care providers about the fact that they are using it. Dr Geller: People get patents for other drugs. in some sense. What is your position on this? Dr Geller: I would love to see more rigorous study. How do you standardize it? If you really think it works better. or form be done by the pharmaceutical companies that developed the products. PhD ALTERNATIVE THERAPIES. I’m not going to do ‘traditional’ hormone therapy. From my perspective. “Okay.” and women don’t think of these as medications. but I don’t think we fully understand the beneﬁts and risks of possibly overmedicating women with drugs not designed for the menopause transition. NO. clinical trials should not in any way. and none of us showed an effect for black cohosh. the only thing hormone therapy is good for is for some short-term menopausal symptoms. is that there is little proﬁt incentive because of the nonpatentability of most of the products. Providers ask. and then they do the clinical trials. randomized clinical trials where we not only study efficacy and safety but we work with pharmacy people to understand mechanism of action—I think that is a critical piece—and we work to develop standardized extracts. seem to help with hot ﬂashes. Conversations: Stacie Geller. of course. too. In fact. but I’m going to do bioidentical hormone therapy because that’s going to be natural and therefore safe. I was shocked when we unmasked our data.if we don’t study it. would probably say that they standardize it differently.” That is another problem: a lot of these groups develop their own products through working with pharmaceutical companies. which are for depression. From my perspective. they cannot be assumed to be any safer than other hormone therapy. that has a pretty good safety proﬁle. Share the science. These were really well crafted. we know less about them. VOL. There are three good randomized controlled trials in the United States on this: the one we did. I don’t know of one. They must be done by independent researchers. therefore safer. “What other medications are you on?. But no one has studied the long-term implications of putting nondepressed women on antidepressive medication for hot ﬂashes. There are alternatives to hormones. There needs to be more rigor about how the products are taken to market. shape. right? So I do think there can be some way to patent the products. so they say nothing. But from my perspective. that has been used for a long time. Now there is interest in bioidentical hormones. That’s not where the science is taking us. There are no long-term safety data. ATHM: Are these studies the tolling bell for black cohosh and red clover in terms of the science not showing their ability to alleviate menopausal symptoms? Dr Geller: I certainly think it is for the product that we used. which means more FDA control. Do I think women are going to stop using it because of these studies? No. but would it be better than what we have now? I think so. Is the FDA perfect? No.
and I think it would be fascinating to try to tease out the independent effects of menopause on chronic conditions and aging on chronic conditions. as well as diet and exercise on promoting good health? I also think the government needs to take a much broader 72 ALTERNATIVE THERAPIES. they learned through continuing medical education. and I won’t take hormone therapy. black cohosh may have quite a reasonable effect on reducing hot ﬂashes. But the good news was they were open to learning more about these products and they were even open to prescribing them if they knew the supplements worked and were safe. This study is trying to understand the transition women go through in the perimenopause and menopause.” would I tell her about black cohosh? I would because chances are she is going to either get better from the black cohosh—if it has some effect we don’t know about—or she’s going to have a placebo effect. and I do mean sadly. ATHM: Where should the federal government be directing its research resources? Dr Geller: I was at an NIH meeting recently and was asked that very same question. which I know are good. there is a study I’d be interested in pursuing. jan/feb 2010. We should spend a lot more time studying prevention and promoting healthy lifestyle behaviors. and most of them knew very little about these products. There have been several good clinical trials that show that it’s quite efﬁcacious for mild to moderate depression as compared to placebo. I think the federal government should spend a lot more on women’s health across the lifespan and not just on reproductive and maternal health. We did a survey in which we asked health care providers who took care of menopausal women how much they knew about botanical dietary supplements. if they used them. they had learned nothing about botanical dietary supplements in medical school. This was before the randomized clinical trials happening in the United States were complete. and if they were open to using them. Are women at increasing risk of heart disease because they are going through menopause and their estrogen levels are decreasing. 1 Conversations: Stacie Geller. Women go through menopause simultaneous to aging. I have serious misgivings. healthy environment. or is it because they are aging and this is the age at which women become a higher risk. And I raised the study I just mentioned as a possible way to try to understand menopause and the aging process. and we needed to see what they showed. the conversation isn’t as positive as it once was. and I probably would have been one of them. If a woman came to me and said. because I think women should have alternatives. Look at St John’s wort. They believed that their patients were using these products and thought it important that they knew something about them. that don’t randomize women into one group or another. Anything they knew. One of the things I said is we need more studies across a woman’s lifespan—more studies of girls and women. They are not all standardized exactly the same. There are some people who would say that about black cohosh. ATHM: Are there other areas within the study of menopause that you are interested in studying? Dr Geller: Outside of alternative therapies. and I have been saying that based on the preliminary available data. nothing in residency—even if they had just graduated. certainly within mainstream medicine. What is the impact of healthy foods. I’ve been doing lectures for health care providers and health consumers for a while. I think those kinds of studies—that have both qualitative and quantitative data.ATHM: There appears to be a lot of resistance within academia. PhD . “I’m really miserable. but based on the most recent data. to integrative medicine and integrative therapies. VOL. 16. or is it an interaction between the two? It would be a very hard study to do. NO. these trials haven’t shown that these products work. as opposed to always studying disease. for example. but study the natural process of aging—are critical to do. and I don’t have an issue with placebo effect. Sadly. There was also a large longitudinal study called SWAN. but they are all variations on a theme. and healthy water. Study of Women Across the Nation. Of course. How does this conversation look going forward as you work with these groups? Dr Geller: Unfortunately. but it would be interesting. They didn’t recommend use and they didn’t ask their patients if they used these supplements.
That is a big part of the work I do. Beside the dissemination issue. it was published. VOL. meaning about half of the class going into medical school is female. jan/feb 2010. ﬁll all of these positions. and we need to do more of that here. ATHM: You are also very involved in mentoring students and faculty both in research and medicine. and additional funding is required for the scientists to take that last step of dissemination. But when you look at promotion and tenure and leadership and high-level positions in medicine. and we would never. Conversations: Stacie Geller. there is a huge disparity between men and women that exists to this day. they are thrilled to go through menopause because they are no longer fertile. this information should go back to the community of health care providers and the community of health consumers. 1 73 . ATHM: You were the coauthor on a 2008 study investigating women’s leadership in academic medicine and the concept of a glass ceiling. I think all of this. What we see in medicine is that the pipeline is full. it’s not. “No comment”? I will say that women would be better off talking to scientists and their health care providers than listening to celebrities who have products to sell. But in fact. What were the results of that study? What are the implications for medicine at large? Dr Geller: That’s the other hat I wear here when I’m not doing research. PhD ALTERNATIVE THERAPIES. But then when you look at the entry into academic medicine for faculty positions. women will eventually. But they don’t want medicine for it. in fact. ever get away with going into a country and doing a study and then leaving without doing a full-country dissemination meeting. fellows. it goes down somewhat. Filling the pipeline is an important piece. over a 10-year period. and I did my ﬁnal report for NIH. not quite. but there is a disparity. It’s an interesting phenomenon because I’m forced to deal with it from the other side when I’m there. In fact. I’m done. and a lot of junior and midcareer faculty. I do a lot of maternal health research. of the residency class is female. primarily women and under-represented minorities. In these countries women use a lot of “nontraditional” medicine for postpartum hemorrhage that doesn’t work. Can I say. At a junior level. But. For example. that has not happened. I wrote an academic paper. What does it mean to go through menopause? If they get really hot or they have trouble sleeping. And for minorities the data is even worse. For example. and I have an NIH grant to mentor junior faculty engaged in women’s health research. are not interested in any medicine for menopause. it is a necessary but not sufﬁcient component for solving the problem. We are still working on these issues. Dr Geller: No. especially developing countries on the African continent and in India. The ﬁeld of medicine is a good example of why this work needs to be done. To them. ATHM: You spend a lot of time conducting research into women’s issues in other countries. I do a lot of career development work. and how do you feel it ﬁts into the big picture? Dr Geller: I mentor doctoral students. I just ﬁnished a randomized clinical trial on treatments for menopausal symptoms.view of women’s health and spend money on translating the science to the community. There are more men than women going into academia. The original thought was that if you ﬁll the pipeline. They have a completely different response to the idea of menopause. the career W Dr Geller: The whole issue of menopause is very different. and it gets in the way of using the very simple medicines that we know do work for decreasing bleeding. It is just understood that you give back to the community and the country. and then they are really at peace. As far as the academic world goes. What drove you to this. They just want to understand the process so they won’t think that there is something else wrong with them. the research. it’s a natural process. Almost half. what other differences do you see in doing your work around the world vs what you see in the United States? ATHM: That’s not the direction Suzanne Somers would want to take that conversation. they understand it. there is still not a huge disparity. primarily postpartum hemorrhage in India and Africa since that is the leading cause of maternal mortality and morbidity. the mothers and grandmothers of the women delivering. NO. The translation of the science to the public and to the medical community is a critical role that the federal government needs to take on. Another example is that the menopausal women. I do a lot of global health work. OMEN WOULD BE BETTER OFF TALKING TO SCIENTISTS AND THEIR HEALTH CARE PROVIDERS THAN LISTENING TO CELEBRITIES WHO HAVE PRODUCTS TO SELL. What is important to them is to understand what’s normal. and that means no more babies. 16. and there will be equality. There are a lot of other reasons why women don’t get promoted and rise to the top and why they drop out of medicine.
Alternative Therapies in Health and Medicine. they were the Jewish people. I identify first and foremost as a woman.development. For more submissions information and guidelines.com. the clinical care. my mother’s mother. VOL. indexed in the National Library of Medicine. and health: the human experience of health. the mentoring. Suite 205 • Boulder. treatment. meta-analyses. social. PhD PM 7/18/07 3:46:47 . and spiritual factors in health promotion and the prevention. and maternal-child health really means focusing on the baby. No one thought about the women. For example. We are especially interested in review articles. body. I think women have gone through a lot around the world. used to say when she thought of her people. who was Jewish. We are most interested in original research. When I think of who my people are. Call for Papers InnoVision Health Media invites submissions for its peer-reviewed medical journals. For more submissions information and guidelines. but an unanswered question while countries move toward increasing circumcision is. CO 80301 • Ph: 303. 1 Conversations: Stacie Geller. botanicals. Papers most likely to be published are those that pass peer review and present authoritative information on the integration of complementary and alternative therapies with conventional medical practices. vigorous debate. and promoting health. That is wonderful news for African men. We talk about maternal-child health. and research reports. and lifestyle. Innovision Health Media • 2995 Wilderness Place. theoretical models. diet. “What are the implications for the women?” If fewer men are getting HIV.com. spirit.7402 • Fax: 303. and healing of illness. opinion and commentary. case reports. illness. review articles.7446 IVHM_CFP. and careful analysis. jan/feb 2010. Papers most likely to be accepted for publication are those that present authoritative information on the integration of alternative therapies with conventional medical practices in preventing and treating disease. will fewer women get HIV? Will there be riskier sexual behavior with more unintended pregnancy and a higher risk of sexually transmitted infection because men will be less likely to use condoms? Health policy and practice are changing.440. and medical care and the clinical. NO. Advances in Mind-Body Medicine explores the relationship between mind.440. my grandmother. It’s different in America certainly than in Africa and Southeast Asia where I work. For more submissions information and guidelines. We are particularly interested in articles that focus on the use of nutritional supplements. case reports. and personal implications of a medicine that acknowledges the whole person. We often focus on the mother so we can improve the health of the baby and have a healthy newborn.com. You’re not going to have a healthy newborn without a healthy mother. social. brief reports. all with a distinct focus on integrative medicine. HEALTH MEDIA INC. She came through hard times. We are looking for fresh thinking. visit imjournal. practical information about the integration of conventional and natural medicine. When I was young. Integrative Medicine: A Clinician’s Journal provides clinicians with scientiﬁcally accurate. and research letters. but I think so often the women get forgotten in health care.indd 1 74 ALTERNATIVE THERAPIES. Papers most likely to be accepted for consideration present authoritative information and compelling points of view on the role of psychological. all of it is about remembering the women. some of the recent research has shown that for the men who got circumcised later in life. healing illness. visit advancesjournal. 16. but there are no clear answers to these questions. visit alternative-therapies. the risk of HIV was dramatically reduced. and in the early days. is an international scientiﬁc forum for the dissemination of peer-reviewed information to healthcare professionals regarding the use of complementary and alternative therapies in promoting health and healing.
This action might not be possible to undo. Are you sure you want to continue?
We've moved you to where you read on your other device.
Get the full title to continue listening from where you left off, or restart the preview.